Silexion Therapeutics Ltd... (SLXN)
NASDAQ: SLXN
· Real-Time Price · USD
3.75
-0.03 (-0.79%)
At close: Oct 15, 2025, 3:59 PM
3.72
-0.80%
After-hours: Oct 15, 2025, 04:21 PM EDT
-0.79% (1D)
| Bid | 3.72 |
| Market Cap | 2.1M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -17.84M |
| EPS (ttm) | -30.78 |
| PE Ratio (ttm) | -0.12 |
| Forward PE | -0.5 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.82 |
| Volume | 58,068 |
| Avg. Volume (20D) | 501,901 |
| Open | 3.78 |
| Previous Close | 3.78 |
| Day's Range | 3.72 - 3.82 |
| 52-Week Range | 3.10 - 63.45 |
| Beta | -0.07 |
| Ex-Dividend Date | n/a |
About SLXN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SLXN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SLXN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.8%
Silynxcom shares are trading higher after the comp...
Unlock content with
Pro Subscription
2 months ago
+31.98%
Silexion Therapeutics shares are trading higher after the company announced it's preparing a Phase 2/3 clinical trial for SIL204.
